National Health Investors (NYSE:NHI) Downgraded to Hold at StockNews.com

National Health Investors (NYSE:NHI) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued on Tuesday.

Other analysts have also issued reports about the stock. Bank of America assumed coverage on shares of National Health Investors in a report on Tuesday, September 24th. They issued a “buy” rating and a $92.00 price objective on the stock. Wells Fargo & Company lowered shares of National Health Investors from an “overweight” rating to an “equal weight” rating and boosted their price objective for the company from $81.00 to $86.00 in a report on Tuesday, October 1st. Finally, Truist Financial boosted their price objective on shares of National Health Investors from $65.00 to $78.00 and gave the company a “hold” rating in a report on Friday, August 30th. Four analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat, National Health Investors has a consensus rating of “Moderate Buy” and an average price target of $73.29.

National Health Investors Stock Performance

Shares of NHI stock opened at $78.11 on Tuesday. The company has a market capitalization of $3.39 billion, a P/E ratio of 25.61, a P/E/G ratio of 4.78 and a beta of 1.04. The business’s 50 day moving average is $80.37 and its two-hundred day moving average is $71.44. The company has a current ratio of 10.27, a quick ratio of 10.27 and a debt-to-equity ratio of 0.91. National Health Investors has a 12-month low of $48.51 and a 12-month high of $86.13.

National Health Investors (NYSE:NHI) last posted its quarterly earnings results on Tuesday, August 6th. The real estate investment trust reported $0.81 EPS for the quarter, missing the consensus estimate of $1.10 by ($0.29). National Health Investors had a net margin of 39.11% and a return on equity of 10.11%. The company had revenue of $84.97 million during the quarter, compared to analyst estimates of $64.95 million. During the same period in the prior year, the business posted $1.06 EPS. National Health Investors’s revenue for the quarter was up 9.1% compared to the same quarter last year. Analysts expect that National Health Investors will post 4.55 EPS for the current fiscal year.

Institutional Investors Weigh In On National Health Investors

Several institutional investors have recently added to or reduced their stakes in the business. Strategic Financial Concepts LLC purchased a new stake in National Health Investors in the second quarter valued at approximately $28,000. Compass Wealth Management LLC purchased a new position in National Health Investors during the first quarter worth about $30,000. International Assets Investment Management LLC purchased a new position in National Health Investors during the second quarter worth about $36,000. Blue Trust Inc. raised its holdings in shares of National Health Investors by 2,651.9% in the 2nd quarter. Blue Trust Inc. now owns 743 shares of the real estate investment trust’s stock worth $47,000 after purchasing an additional 716 shares during the period. Finally, USA Financial Formulas raised its holdings in shares of National Health Investors by 172.8% in the 3rd quarter. USA Financial Formulas now owns 922 shares of the real estate investment trust’s stock worth $78,000 after purchasing an additional 584 shares during the period. Hedge funds and other institutional investors own 62.51% of the company’s stock.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.